Aurobindo Pharma LtdNSE: AUROPHARMA

Press Release Nov 30 2023

· Issued by Aurobindo Pharma Ltd

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-nov-30-2023-2

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated November 30, 2023, titled "Eugia Pharma, a 100% subsidiary receives USFDA approval for Budesonide Inhalation Suspension".

View Attachment

6ix hasn’t read this filing yet.

Aurobindo Pharma Ltd on 6ix

Earlier from Aurobindo Pharma

Later from Aurobindo Pharma

All Aurobindo Pharma news releases